EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort

Murat Torgutalp iD, Valeria Rios Rodriguez iD, Fabian Proft iD, Mikhail Protopopov, Judith Rademacher iD, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy iD

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.43447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Murat Torgutalp und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité - Universitätsmedizin Berlin, Freie Universität…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Cyclooxygenase 2 Inhibitors, Axial Spondyloarthritis, Spine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to investigate the impact of nonsteroidal anti‐inflammatory drug (NSAID) intake on radiographic spinal progression in axial spondyloarthritis (axSpA), considering different NSAID types (COX‐2 inhibitors [COX2i] and nonselective NSAIDs [ns‐NSAIDs]) and disease subgroups (radiographic [r‐axSpA] and nonradiographic [nr‐axSpA]).

Methods

Leveraging data from the German Spondyloarthritis Inception Cohort (GESPIC), we conducted analyses on 252 patients with axSpA (139 with nr‐axSpA and 113 with r‐axSpA), who had minimum two sets of spinal radiographs. The outcome was progression in modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) in two‐year intervals. We fitted sequential conditional mean models by using generalized estimating equations and adjusting for longitudinal repeated measures of exposure and time‐dependent confounders. We report β‐coefficients with 95% confidence intervals (CIs) for outcomes reflecting the progression in mSASSS per 10‐point increase in NSAID intake score.

Results

At baseline, 201 (80.0%) patients were under NSAID treatment, with 46 (18%) taking COX2i and 156 (62%) taking ns‐NSAIDs, and mean total NSAID intake score was 38.3 ± 35.5. A 10‐point increase in NSAID intake score was associated with retardation of radiographic progression (β = −0.052, 95% CI: −0.097 to −0.007), with this effect being most pronounced in patients with r‐axSpA (β = −0.077, 95% CI: −0.152 to −0.003). COX2i showed a slightly lower point estimate (although not statistically significant) in progression compared to ns‐NSAIDs among all patients with axSpA (β = −0.061 and −0.045, respectively).

Conclusion

Our findings suggest a beneficial effect of higher NSAID intake, particularly COX2i, on slowing radiographic progression in axSpA. These findings may help inform therapeutic strategies, particularly in r‐axSpA, although further research is needed for nr‐axSpA. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsAxial SpondyloarthritisSpineHumansDisease ProgressionMaleFemaleAdultRadiographyMiddle AgedCohort Studies

Substanzen

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology, Berlin, Germany.
  • Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany.

ORCID-Profile: Murat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, Judith Rademacher, Denis Poddubnyy

Zitieren

APA

Torgutalp, M., Rios Rodriguez, V., Proft, F., Protopopov, M., Rademacher, J., Haibel, H., Sieper, J., Rudwaleit, M., & Poddubnyy, D. (2026). The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort. Arthritis & Rheumatology. https://doi.org/10.1002/art.43447

Vancouver

Torgutalp M, Rios Rodriguez V, Proft F, Protopopov M, Rademacher J, Haibel H, et al. The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort. Arthritis & Rheumatology. 2026. doi:10.1002/art.43447

BibTeX
@article{Torgutalp2026,
  author = {Torgutalp, Murat and Rios Rodriguez, Valeria and Proft, Fabian and Protopopov, Mikhail and Rademacher, Judith and Haibel, Hildrun and Sieper, Joachim and Rudwaleit, Martin and Poddubnyy, Denis},
  title = {The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.43447}
}
Kostenlos starten →